- May 12, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Vumerity
Synonyms :
diroximel fumarate
Class :
Multiple Sclerosis Treatments, Immunomodulators
Dosage Forms & Strengths
delayed release, capsule
231mg
Initial dose: 231 mg orally twice a day
Maintenance: may increase to 462 mg (231- of each capsule) After one week, orally twice a day
Not able to tolerate the maintenance dose
If the maintenance dosage is not tolerated, consider reducing the dose temporarily to 231 mg orally twice a day.
Resuming dosage in 4 weeks at 462 mg orally twice a day
If a patient cannot tolerate an increased dose to the maintenance level, consider discontinuing the medication.
Dose Adjustments
Dosage Modifications
Hepatic impairment
Hepatic impairment has not been the subject of any studies.
No dose adjustments are required since it is not expected to affect the exposure of monomethyl fumarate (MMF).
Renal impairment
Mild: dose adjustment is not required
Moderate to severe: usually not recommended
Safety & efficacy were not established
Refer to the adult dosing regimen
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect of vaccines
measles mumps and rubella vaccine, live
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
vaccinia immune globulin intravenous (Rx)
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
poliovirus vaccine, live, trivalent
may diminish the therapeutic effect of vaccines
poliovirus vaccine inactivated
may diminish the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect of vaccines
measles mumps and rubella vaccine, live
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may reduce the therapeutic effect of vaccines
may have a decreased therapeutic effect when combined with covid-19 vaccine
Immunosuppressants may reduce the therapeutic effect of COVID-19 Vaccine
it may enhance the immunosuppressive effect of Immunosuppressants
it may diminish the therapeutic effect of Influenza Virus Vaccines
influenza virus vaccine h n live
it may diminish the therapeutic effect of Influenza Virus Vaccines
influenza virus vaccine (h n ) adjuvanted
it may diminish the therapeutic effect of Influenza Virus Vaccines
it may diminish the therapeutic effect of Influenza Virus Vaccines
poliovirus vaccine, live, trivalent
immunosuppressants may diminish the therapeutic effect of Vaccines
poliovirus vaccine inactivated
immunosuppressants may diminish the therapeutic effect of Vaccines
immunosuppressants may diminish the therapeutic effect of vaccines
vaccinia immune globulin intravenous (Rx)
immunosuppressants may diminish the therapeutic effect of vaccines
immunosuppressants may diminish the therapeutic effect of vaccines
immunosuppressants may diminish the therapeutic effect of vaccines
immunosuppressants may diminish the therapeutic effect of vaccines
may decrease the therapeutic effect of COVID-19 vaccine
may increase the immunosuppressive effect of tacrolimus
may decrease the therapeutic effect when combined with sipuleucel-t
may decrease the therapeutic effect when combined with vaccines
may decrease the diagnostic effect when combined with coccidioides immitis test
belimumab's immunosuppressive properties reduce the efficacy of the live rotavirus oral vaccine, leading to diminished effects
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of Immunosuppressants
respiratory syncytial virus vaccine, adjuvanted
may increase the immunosuppressive effect of Immunosuppressants
respiratory syncytial virus (RSV) vaccine
may increase the immunosuppressive effect of Immunosuppressants
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
vaccinia immune globulin intravenous (Rx)
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
poliovirus vaccine, live, trivalent
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
poliovirus vaccine inactivated
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
smallpox (vaccinia) vaccine, live
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
Immunosuppressants may enhance the adverse/toxic effect of Vaccines
It may enhance the immunosuppressive effects when combined with idecabtagene vicleucel
immunosuppressants may enhance the adverse/toxic effect of dengue Vaccine
Immunosuppressants may enhance the adverse/toxic effect of Vaccines